Overview on the use of recombinant humanized thyroid stimulating hormone (rhTSH) in the treatment and follow-up of patients with thyroid cancer

被引：0
|
作者：
Koutsikos, John
Velidaki, Antigoni
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1898
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer
    Bombardieri, E
    Seregni, E
    Villano, C
    Aliberti, G
    Mattavelli, F
    TUMORI JOURNAL, 2003, 89 (05): : 533 - 536
  • [2] The importance of recombinant human. thyroid stimulating hormone in the follow-up and treatment of disseminated thyroid cancer after thyroidectomy
    Skoura, Evangelia
    Rontogianni, Phivi
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (01): : 40 - 47
  • [3] Follow-up of thyroid cancer patients using rhTSH -: preliminary results
    Petrich, T
    Börner, AR
    Weckesser, E
    Soudah, B
    Otto, D
    Widjaja, A
    Hofmann, M
    Kreipe, HH
    Knapp, WH
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2001, 40 (01): : 7 - 14
  • [4] Follow-up of differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after recombinant human thyrotropin (rhTSH) or thyroid hormone withdrawal
    Elisei, R.
    Corone, C.
    Driedger, A.
    Haugen, B. R.
    Kloos, R. T.
    Magner, J.
    Pacini, F.
    Luster, M.
    Schlumberger, M.
    Sherman, S.
    Pinchera, A.
    Ladenson, P. W.
    HORMONE RESEARCH, 2007, 68 : 33 - 33
  • [5] The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Basaria, M
    Graf, H
    Cooper, DS
    AMERICAN JOURNAL OF MEDICINE, 2002, 112 (09): : 721 - 725
  • [6] Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer
    Freudenthal, B.
    Williams, G. R.
    CLINICAL ONCOLOGY, 2017, 29 (05) : 325 - 328
  • [7] Use of recombinant human thyroid-stimulating hormone (rhTSH) reduces the damage to salivary glands after radioiodine therapy for thyroid cancer
    Isoda, Takuro
    Baba, Shingo
    Maruoka, Yasuhiro
    Kitamura, Yoshiyuki
    Sasaki, Masayuki
    Honda, Hiroshi
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution
    Wong, R.
    Topliss, D. J.
    Bach, L. A.
    Hamblin, P. S.
    Kalff, V.
    Long, F.
    Stockigt, J. R.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (03) : 156 - 163
  • [9] Clinical experience with recombinant human thyrotropin (rhTSH) in the follow-up of differentiated thyroid carcinoma
    Queiros, J.
    Neves, C.
    Carvalho, D.
    Lopes, F.
    Cavadinha, M.
    Veiga, F.
    Magalhaes, A.
    Medina, J. L.
    HORMONE RESEARCH, 2007, 68 : 42 - 42
  • [10] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40
12345